The dolphins are jumping outside my window as the shrimp boat trolls the Atlantic. There are women chatting happily in the kitchen and the retreat is in full swing. What a glorious day to be alive and to be an … Continue reading
I have been exposed to a lot of life wisdom. A lot of it. And I forget it. That’s why I need constant reminders to bring the important stuff in the back of my ADD brain back up to the … Continue reading
Well, I planted my garden late (not entirely procrastination though, since I was finishing my book at the height of planting season). My squash and zucchini are late. But now that they are coming in, oh baby! I can … Continue reading
I am just about to put a small batch of homemade scones in the oven for a good friend and ADDiva MK who is convalescing from hip replacement surgery. She’s staying at GardenSpirit Guesthouse for a week or so until … Continue reading
Great news for all of you! Twelve hours of interviews with world experts on ADHD next week and they are absolutely F.R.EE! It’s the very first "Succeed with ADHD Web Summit" (http://tiny NULL.cc NULL.adhdsummit)and I am honored to be an … Continue reading
Landed in Amsterdam yesterday and wondering if there are any ADDivas in the Netherlands.
Would love to connect if you’re available. I love ADDiva dining – ask anyone! Continue reading
In yet another consumer-bashing move, the US Supreme Court ruled June 23, 2011, that pharmaceutical companies may now purchase lists of the drugs that individual doctors prescribe (without the name of the patient) for marketing purposes.
The ruling was made using the First Amendment Freedom of Speech argument that if researchers and journalist were allowed to gather such records, then marketers deserved equal access. Um, this doesn’t exactly seem like freedom of speech to me. It’s more like data mining. And that pretty much sucks. Continue reading
But what about our safety and our right to full disclosure? Is the tradeoff for cheaper prescription prices an incomplete warning label about a potentially long-term, debilitating neurological condition? In this case, apparently so.
What does this mean for generic manufacturers? That they may skip merrily down the road producing medications that may or may not negatively impact the end user without telling us about newly-discovered problems.
What does this mean for ADD medications? It means “caveat emptor” – let the buyer beware. The drugs that are “off patent” may or may not have new, serious side effects. But if we take a generic we’ll never know, because there is no requirement that we be told about them. And now, no way to seek legal recourse against the company that produced the drug. Continue reading
All those long worrisome nights are gone! The sun shines brightly even when it’s raining! And "Confessions of an ADDiva: Midlife in the non-linear lane" is DONE! Yes, my dear ADDiva friends, I have finally finished my dream book and … Continue reading
Last night was the Triangle Adult ADHD Meetup and I played portions of Dr. Russell Barkley’s CHADD keynote about emotion and ADHD. It was well received, even though some of his assertions are still controversial and unproven. You can catch … Continue reading
|
|
|
|
